Anesthesia Management via an Automated Control System for Propofol, Remifentanil, and Rocuronium Compared to Management by Anesthesiologists: An Investigator-Initiated Study
- PMID: 37892749
- PMCID: PMC10607889
- DOI: 10.3390/jcm12206611
Anesthesia Management via an Automated Control System for Propofol, Remifentanil, and Rocuronium Compared to Management by Anesthesiologists: An Investigator-Initiated Study
Abstract
Background: We previously developed an automated total intravenous anesthesia control system that uses new closed-loop system algorithms to administer propofol, remifentanil, and rocuronium based on the bispectral index and train-of-four data. We recently improved this automated control system by adding a safety mechanism and using a modified monitoring device.
Methods: Patients scheduled for elective surgery were randomly assigned to closed-loop feedback control (automatic group) or the manual administration of propofol, remifentanil, and rocuronium (manual group). The proportion of time during which the proper management of three-agent anesthesia was maintained during surgery was determined as the primary endpoint.
Results: The proportion of time during which the three components of sedation, analgesia, and muscle relaxation were adequately controlled was 87.21 ± 12.79% in the automatic group, which was non-inferior to the proportion of 65.19 ± 20.16% in the manual group (p < 0.001). Adverse events during the operative or postoperative observation periods were significantly less frequent in the automatic group (54 patients, 90.0%) than in the manual group (60 patients, 100.0%; p = 0.027).
Conclusion: Our three-agent automated control system, which features an improved muscle relaxation monitor and safety mechanism added to the basic control algorithms, maintained sedation, analgesia, and muscle relaxation appropriately in a manner non-inferior to anesthesiologists without compromising safety.
Keywords: anesthesia; automated control system; closed-loop control; propofol; remifentanil; rocuronium.
Conflict of interest statement
The authors disclose that the Nihon Kohden Corporation (NKC) provided control software in accordance with the Clinical Trials Act in Japan. The NKC received funding as a joint research partner from AMED to cover the development of the control software.
Figures
References
-
- De Smet T., Struys M.M.R.F., Greenwald S., Mortier E.P., Shafer S.L. Estimation of Optimal Modeling Weights for a Bayesian-Based Closed-Loop System for Propofol Administration Using the Bispectral Index as a Controlled Variable: A Simulation Study. Anesth. Analg. 2007;105:1629–1638. doi: 10.1213/01.ane.0000287269.06170.0f. - DOI - PubMed
-
- Simanski O., Janda M., Schubert A., Bajorat J., Hofmockel R., Lampe B. Progress of automatic drug delivery in anesthesia: The ‘Rostock assistant system for anesthesia control (RAN)’. Int. Adapt. Control Signal Process. 2009;23:504–521. doi: 10.1002/acs.1068. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
